Leaky gut and diabetes mellitus: what is the link? (Q37850489)

24 August 2017

1 reference

title

Leaky gut and diabetes mellitus: what is the link? (English)

1 reference

24 August 2017

D. Keszthelyi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21382153

26 November 2024

S. de Kort

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21382153

26 November 2024

A. A M. Masclee

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21382153

26 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21382153

26 November 2024

publication date

8 March 2011

1 reference

full work available at URL

24 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1467-789X.2010.00845.x

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1467-789X.2010.00845.x/fullpdf

26 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

26 November 2024

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

449-458

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Alterations in intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Physiology and function of the tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Intestinal barrier function: molecular regulation and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Intestinal permeability in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Leaking gut in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Dietary insulin as an immunogen and tolerogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Beneficial effects of Bacteroides fragilis polysaccharides on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Mechanisms of obesity-associated insulin resistance: many choices on the menu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Nutrient sensing and inflammation in metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Butyrate improves insulin sensitivity and increases energy expenditure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Butyrate modulates oxidative stress in the colonic mucosa of healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

21 January 2018

Glucagon-like Peptide-2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Biologic actions and therapeutic potential of the proglucagon-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Translational research into gut microbiota: new horizons in obesity treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Gut microflora as a target for energy and metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00845.X

Abnormal intestinal permeability to sugars in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Increased intestinal permeability precedes clinical onset of type 1 diabetes

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Detection of enteroviruses in the intestine of type 1 diabetic patients

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Intestinal growth-promoting properties of glucagon-like peptide-2 in mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Gluten-free diet prevents diabetes in NOD mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108

26 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1467-789X.2010.00845.X

26 November 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference